Singulex Obtains $2,175,822 New Financing Round

  • Feed Type
  • Date
    8/8/2011
  • Company Name
    Singulex
  • Mailing Address
    1650 Harbor Bay Parkway Alameda, CA 94502
  • Company Description
    Singulex is an early stage biotechnology company with research and development laboratories in St. Louis and commercial operations in Hayward, California.

    Singulex has obtained exclusive license to all intellectual property around its core technology and has further fortified this position. Our business model builds upon both the immediate and longer term needs in therapeutic discovery/development and eventually human disease management through improved diagnostics.

  • Website
    http://www.singulex.com
  • Transaction Type
    Debt, Venture Equity
  • Transaction Amount
    $2,175,822
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. Amount may include options, warrants, other rights to acquire other securities and subordinated convertible promissory notes. SEC regulatory filing-amended.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.